Outcome of patients with unfavorable optimally cytoreduced ovarian cancer treated with chemotherapy and whole abdominal radiation
- 30 April 1991
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 41 (1) , 30-35
- https://doi.org/10.1016/0090-8258(91)90250-9
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Whole abdominal irradiation following chemotherapy in patients with minimal residual disease after second look surgery in ovarian carcinomaInternational Journal of Radiation Oncology*Biology*Physics, 1989
- Postoperative abdominopelvic radiation therapy for ovarian cancerInternational Journal of Radiation Oncology*Biology*Physics, 1988
- A randomized study of cyclophosphamide and cis-platinum with or without doxorubicin in advanced ovarian carcinomaGynecologic Oncology, 1987
- Advanced epithelial ovarian cancer: Toxicity of whole abdominal irradiation after operation, combination chemotherapy, and reoperationGynecologic Oncology, 1986
- The Will Rogers PhenomenonNew England Journal of Medicine, 1985
- Whole abdominal and pelvic irradiation in patients with minimal disease at second-look surgical reassessment for ovarian carcinomaGynecologic Oncology, 1985
- RANDOMISED TRIAL COMPARING LOW-DOSE CISPLATIN AND CHLORAMBUCIL WITH LOW-DOSE CISPLATIN, CHLORAMBUCIL, AND DOXORUBICIN IN ADVANCED OVARIAN CARCINOMAThe Lancet, 1981
- A Generalized Wilcoxon Test for Comparing Arbitrarily Singly-Censored SamplesBiometrika, 1965
- A generalized Wilcoxon test for comparing arbitrarily singly-censored samplesBiometrika, 1965
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958